FindTrial
Sign In

Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.

Clinical Professor of Shanghai Tongji Hospital

Status
APPROVED_FOR_MARKETING
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT02969174
Enrollment
Unknown
Registered
2016-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2016-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HDFN

Brief summary

To establish a genotyping and extraction technology of non invasive prenatal diagnosis for fetal blood group genotype from cell-free fetal DNA in peripheral blood of pregnant women. To achieve prenatal accurate identification of fetal blood group genotypes，and provide credible theoretical evidence for the prenatal diagnosis and treatment of hemolytic disease of newborn (HDN).

Detailed description

Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.

Interventions

OTHERzimin Lu,Guo Sa

chengzhong Liu

Sponsors

Shanghai Tongji Hospital, Tongji University School of Medicine
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
12 Weeks to 38 Weeks

Inclusion criteria

blood samples of pregnant couples,gender/nation/region is unlimited.

Exclusion criteria

adipose or hemolytic samples,overdue samples,unidentified samples

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026